94
Participants
Start Date
November 14, 2024
Primary Completion Date
October 31, 2027
Study Completion Date
June 30, 2030
Sonrotoclax
Administered orally
Zanubrutinib
Administered orally
Hospital Clinic de Barcelona, Barcelona
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, Brescia
Clinica Universidad de Navarra, Madrid
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Clinica Universidad de Navarra Pamplona, Pamplona
Hospital de Cabuenes, Gijón
Universita Degli Studi Di Modena Azienda Ospedaliere Policlinco, Modena
Aou Careggi, Servizio Sanitario Toscana, Florence
University of Nebraska Medical Center, Omaha
Utah Cancer Specialists, Salt Lake City
Aoor Villa Sofia Cervello, Palermo
Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
Jiangsu Province Hospital, Nanjing
The First Peoples Hospital of Changzhou, Changzhou
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Fujian Medical University Union Hospital, Fuzhou
Henan Cancer Hospital, Zhengzhou
University of Miami, Miami
Cleveland Clinic Florida, Weston
Northwest Georgia Oncology Centers Marietta, Marietta
Illinois Cancer Specialists (Niles) Usor, Niles
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Nebraska Cancer Specialists (Satellite Site), Omaha
Nebraska Cancer Specialists, Omaha
Summit Medical Group, Florham Park
New York Cancer and Blood Specialists, Shirley
Texas Oncology Dfw, Dallas
Texas Oncology Tyler, Tyler
Northwest Cancer Specialist, Pc(Us Oncology Research), Vancouver
Centro de Pesquisas Oncologicas Cepon, Florianópolis
Hospital de Clinicas de Porto Alegre, Porto Alegre
Instituto Dor de Pesquisa E Ensino Sao Paulo, São Paulo
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo
Pratia Onkologia Katowice, Katowice
Pratia McM Krakow, Krakow
Uniwersytecki Szpital Kliniczny Nr W Lublinie, Lublin
Uniwersytecki Szpital Kliniczny Hematology, Wroclaw
Lead Sponsor
BeOne Medicines
INDUSTRY